Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
04/09/2014 04/10/2014 04/11/2014 04/16/2014 04/17/2014 Date
8.5 8.45 8.07 7.83 8.24 Last
5388 8745 10950 5257 17345 Volume
+3.91% -0.59% -4.50% -2.97% +5.24% Change
Company
Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world. Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent... 
Sector
Biotechnology
Calendar
05/19Earnings Release
Surperformance© rating of Cardiome Pharma Corp.
Trading Rating : Investor Rating :
More about the company
Chart CARDIOME PHARMA CORP.
Duration : Period :
Cardiome Pharma Corp. Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Financials ( CAD)
Sales 2014 36,5 M
EBIT 2014 -5,43 M
Net income 2014 -1,38 M
Debt 2014 -
Yield 2014 -
Sales 2015 42,3 M
EBIT 2015 1,88 M
Net income 2015 2,95 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015 41,90
Capi. / Sales 2014 3,39x
Capi. / Sales 2015 2,92x
Capitalization 124 M
More Financials
Latest news on CARDIOME PHARMA CORP.
03/28 CARDIOME PHARMA : Enters Agreement With Vianex S.A. To Commercialize BRINAVESS I..
03/27 CARDIOME PHARMA : Reports Fourth Quarter and Full Year 2013 Financial Results
03/20 CARDIOME PHARMA : To Hold Fourth Quarter And Full Year 2013 Financial Results Co..
03/19 CARDIOME PHARMA : Enters Into an Agreement to Distribute BRINAVESS in Spain
03/18 CARDIOME PHARMA : Announces C$30 Million Primary And Secondary Common Share Offe..
03/18 CARDIOME PHARMA : Announces At-The-Market Offering
03/18 CARDIOME PHARMA : Enters Brinavess Distribution Agreement With Nomeco A/S In Den..
03/18 CARDIOME PHARMA : Announces Update In Commercialization Partnership For BRINAVES..
03/18 CARDIOME PHARMA : Closes C$30 Million Primary And Secondary Common Share Offerin..
03/11 CARDIOME PHARMA CORP. : Cardiome Closes C$30 Million Primary And Secondary Commo..
03/11 CARDIOME PHARMA CORP. : Cardiome Closes C$30 Million Primary And Secondary Commo..
02/20 CARDIOME PHARMA CORP. : Cardiome Announces C$30 Million Primary and Secondary Co..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
Cardiome Pharma Corp. : Income Statement Evolution
More Financials
EPS Revisions
Cardiome Pharma Corp. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF